Back to results
US 2014/0275295 A1Published application
Method for treating type i and type ii diabetes
OwnerHiroyuki Kouji, Takenao Odagamiinventors
Life of this patent
Estimating the term…
Abstract
The present disclosure relates generally to alpha-helix mimetic structures and specifically to alpha-helix mimetic structures that are inhibitors of β-catenin. The disclosure also relates to applications in the treatment of diabetes and diabetic conditions such as diabetic neuropathy, and pharmaceutical compositions comprising such alpha helix mimetic β-catenin inhibitors.
Claims7
An alpha helix mimetic β-catenin inhibitor compound for the treatment of a diabetic condition.
Dependencies are inferred from the claim text.